New nanoparticles can perform gene editing in the lungs, MIT News

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

Inhalable nanoparticles revolutionize treatment for cystic fibrosis and other lung diseases

nanotechnology – NIH Director's Blog

Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

New nanoparticles deliver gene-editing tech directly into the lungs

New nanoparticles deliver gene-editing tech directly into the lungs

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

RTI Newsroom

Bioengineering, Free Full-Text

Novel nanoparticles deliver CRISPR gene editing tools into the cell with much higher efficiency